New arguments for a vasculitic nature of polymyalgia rheumatica using positron emission tomography

Rheumatology

Volumn 38, Issue 5, 1999, Pages 444-447

  Blockmans, D ^a   Maes, A ^a   Stroobants, S ^a   Nuyts, J ^a   Bormans, G ^a   Knockaert, D ^a   Bobbaers, H ^a   Mortelmans, L ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

FDG PET scan; Giant cell arteritis; Polymyalgia rheumatica; Vasculitis

Indexed keywords

FLUORODEOXYGLUCOSE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GIANT CELL ARTERITIS; HUMAN; INFLAMMATION; INTRAVENOUS DRUG ADMINISTRATION; LEG ARTERY; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RHEUMATIC POLYMYALGIA; TEMPORAL ARTERITIS; THORAX; VASCULITIS;

AGED; AORTA, THORACIC; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; POLYMYALGIA RHEUMATICA; RADIOPHARMACEUTICALS; SUBCLAVIAN ARTERY; TEMPORAL ARTERITIS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0032755041     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/38.5.444     Document Type: Article

References (17)

1. Bird HA, Esselinckx W, Dixon ASJ, Mowat AG, Wood PHN. An evaluation of criteria for polymyalgia rheumatica. Ann Rheum Dis 1979;38:434-9.
2. Chuang TY, Hunder GG, Ilstrup DM, Kurland LT. Polymyalgia rheumatica: evidence for synovitis. Ann Intern Med 1982;97:672-80.
3. Healey LA. Long-term follow-up of polymyalgia rheumatica: evidence for synovitis. Semin Arthritis Rheum 1984;13:322-8.
4. van der Woude FJ, Rasmussen N, Lobatto S. Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 1985;i:425-9.
5. Yuasa K, Tokitsu M, Goto H, Kato H, Shimada K. Wegener's granulomatosis: diagnosis by transbronchial lung biopsy, evaluation by gallium scintigraphy and treatment with sulfamethoxazole/trimethoprim. Am J Med 1988;84:371-2.
6. Jonker ND, Peters AM, Gaskin G, Pusey CD, Lavender JP. A retrospective study of radiolabeled granulocyte kinetics in patients with systemic vasculitis. J Nucl Med 1992;33:491-7.
7. Wang SJ, Lan JL, Lin WY, Liu RS, Yeh SH. Three-phase abdominal scintigraphy in lupus vasculitis of the gastrointestinal tract. Clin Nucl Med 1995;20:695-8.
8. Maes A, Flameng W, Nuyts J et al. Histological alterations in chronically hypoperfused myocardium: correlation with PET findings. Circulation 1994;90:735-45.
9. Hawkins RA, Hoh C, Glaspy J et al. The role of positron emission tomography in oncology and other whole-body applications. Semin Nucl Med 1992;22:268-84.
10. Ichiya Y, Kuwabara Y, Sasaki M et al. FDG-PET in infectious lesions: the detection and assessment of lesion activity. Ann Nucl Med 1996;10:185-91.
11. Hunder GG, Bloch DA, Michel BA et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990;33:1122-8.
12. Liuzzo G, Biasucci LM, Gallimore JR et al. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 1994;331:417-24.
13. Haverkate F, Thompson SG, Pyke SDM, Gallimore JR, Pepys MB. Production of C-reactive protein and risk of coronary events in stable and unstable angina. Lancet 1997;349:462-6.
14. Weyand CM, Hicok KC, Hunder GG, Goronzy JJ. Tissue cytokine patterns in patients with polymyalgia rheumatica and giant cell arteritis. Ann Intern Med 1994;121:484-91.
15. Weyand CM, Tetzlaff N, Bjornsson J, Brack A, Younge B, Goronzy JJ. Disease patterns and tissue cytokine profiles in giant cell arteritis. Arthritis Rheum 1997;40:19-26.
16. Paulley JW. Coronary ischaemia and occlusion in giant cell (temporal) arteritis. Acta Med Scand 1980;208: 257-63.
17. Evans JM, Bowles CA, Bjornsson J, Mullaly CJ, Hunder GG. Thoracic aortic aneurysm and rupture in giant cell arteritis. Arthritis Rheum 1994;37:1539-47.